Lower IQ is Associated with Decreased Clinical Response to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder

Author： Mazzone Luigi

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.6, 2011-06, pp. : 503-509

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

By Garnock-Jones Karly P. Keating Gillian M.

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P. Keating Gillian M.

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite

Switching from Neurostimulant Therapy to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder: Clinical Approaches and Review of Current Available Evidence

By Prasad Suyash

Pediatric Drugs, Vol. 10, Iss. 1, 2008-01 ,pp. : 39-47

Adis International

Access to resources Recommend Favorite

Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder

By Bangs Mark E. Jin Ling Zhang Shuyu Desaiah Durisala Allen Albert J. Read Holly A. Regev Arie Wernicke Joachim F.

Drug Safety, Vol. 31, Iss. 4, 2008-01 ,pp. : 345-354

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

By Simpson D. Plosker G.L.

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 397-401

Adis International

Access to resources Recommend Favorite